H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas

Pathania, Manav, De Jay, Nicolas, Maestro, Nicola, Harutyunyan, Ashot S., Nitarska, Justyna, Pahlavan, Pirasteh, Henderson, Stephen, Mikael, Leonie G. +14 more·2017·Cancer Cell

Cited by (265)

Items 201–265 of 265

  1. H3K27me3 loss and METTL3-m6A converge to upregulate SOX11/SMARCA4 and drive H3K27-altered spinal cord glioma stemness and proliferation
    Hao Yan, Jialin Jin, Yuzhou Chang, Bo Pang, Han Lin, Songyuan An, Lanhui Zheng, Boping Liu, Yilin Wu, Wenhao Xia et al. · 2026 · Neuro-Oncology
  2. Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?
    Clément Berthelot, Paul Huchedé, Adrien Bertrand‐Chapel, Pierre-Aurélien Beuriat, Pierre Leblond, Marie Castets · 2024 · International Journal of Molecular Sciences
  3. Pontine Infantile Glioma Simplified
    Vijay Ramaswamy, Michael D. Taylor · 2017 · Cancer Cell
  4. The dark matter of diffuse intrinsic pontine gliomas: an update
    Jacques Grill, Marie-Anne Debily, Pascale Varlet, Alexandre Plessier, Ludivine Le Dret, Kévin Beccaria, Stéphanie Puget, David Castel · 2018 · Expert Opinion on Orphan Drugs
  5. Tails of a Super Histone
    Patrick Sin‐Chan, Iqra Mumal, Annie Huang · 2019 · Cancer Cell
  6. Diffuse Intrinsic Pontine Glioma: Translation of Genomic Knowledge to Clinical Practice
    Tina Z hou, Sara A. Khan, Ron Firestein, Peter Downie, Jason E. Cain · 2019 · OBM Neurobiology
  7. Molecular Advances and Targeted Therapies for Pediatric Central Nervous System Tumors
    Danielle Gordon, Bernard L. Maria · 2020 · Journal of Child Neurology
  8. Glioma stem cells, plasticity, and potential therapeutic vulnerabilities
    Shivani Baisiwala, Jack M. Shireman, Atique U. Ahmed · 2021 · Elsevier eBooks
  9. Chemoresistance mechanisms in mouse models of glioblastoma
    Takamasa Kinoshita, Masafumi Miyai, Toru Iwama, Akira Hara, Hiroyuki Tomita · 2021 · Elsevier eBooks
  10. Animal models of primary brain tumors
    Bradley L. Kolb, Hassan A. Fadel, Neil V. Klinger, Sandeep Mittal · 2019 · Elsevier eBooks
  11. Molecular characteristics of anaplastic astrocytomas and isolation of molecular subgroups of their IDH1 mutant forms using in silico analysis
    Pavel V. Nikitin, Artem Yu. Belyaev, Marina Vladimirovna Ryzhova · 2020 · Bulletin of Siberian Medicine
  12. On the origins of pediatric brain cancer: Exploring the role of genome instability in development and disease
    Irena Bočkaj · 2021
  13. Genomic Instability and the Oncohistone H3K27M Drive Gliomagenesis in a Murine Model
    Lee J. Pribyl · 2020
  14. Loss of the H4 lysine methyltransferase KMT5B drives tumorigenic phenotypes by depleting H3K27me3 at loci otherwise retained in H3K27M mutant DIPG cells
    Ketty Kessler, Alan G. Mackay, Yura Grabovska, Valeria Molinari, Anna Burford, Sara Temelso, Haider Tari, Erika Yara Romero, Ilon Liu, Lu Yu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  15. The diverse landscape of histone-mutant pediatric high-grade gliomas
    Evan Lubanszky, Cynthia E Hawkins · 2022 · Glioma
  16. Faculty Opinions recommendation of H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis.
    Jason T. Huse · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  17. A conditional histone H3.3 mutation in mice orthologous to a driver of paediatric diffuse instrinsic pontine glioma
    Jeff R. Mann, Michelle C. W. Tang, Lee H. Wong · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Cell of Origin of Brain and Spinal Cord Tumors
    Alice Laurenge, Emmanuelle Huillard, Franck Bielle, Ahmed Idbaïh · 2023 · Advances in experimental medicine and biology
  19. Oncohistones
    Kristen Orumaa, Steven G. Gray · 2023 · Elsevier eBooks
  20. Data from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
    Michael McNicholas, Antonella De Cola, Zahedeh Bashardanesh, Amelia Foss, Cameron B. Lloyd, Steven Hébert, Damien Faury, Augusto Faria Andrade, Nada Jabado, Claudia L. Kleinman et al. · 2023
  21. Data from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
    Michael McNicholas, Antonella De Cola, Zahedeh Bashardanesh, Amelia Foss, Cameron B. Lloyd, Steven Hébert, Damien Faury, Augusto Faria Andrade, Nada Jabado, Claudia L. Kleinman et al. · 2023
  22. Methods for ChIP-seq Normalization and Their Application for the Analysis of Regulatory Elements in Brain Cells
    Fedor E. Gusev, Т. В. Андреева, Evgeny Ivanovich Rogaev · 2023 · Russian Journal of Genetics
  23. Additional file 1 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  24. Additional file 3 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  25. Additional file 8 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  26. Additional file 7 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  27. Additional file 2 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  28. Additional file 6 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  29. Additional file 2 of Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas
    Xin Wei, Michaël Hananja Meel, Marjolein Breur, Marianna Bugiani, Esther Hulleman, Timothy N. Phoenix · 2021 · Figshare
  30. Additional file 5 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  31. Methods for ChIP-seq Normalization and Their Application for Analysis of Regulatory Elements in Brain Cells
    Fedor E. Gusev, Т. В. Андреева, Evgeny Ivanovich Rogaev · 2023 · Генетика
  32. A pontine-specific axonal niche supports de novo gliomagenesis
    Zhigang Xie, Adrija Pathak, Vytas A. Bankaitis · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Diffuse Midline Glioma-Pons
    Magimairajan Vanan, Craig Alexander Erker, Vivek Mehta, Cynthia E Hawkins, David D. Eisenstat · 2024 · Springer eBooks
  34. Chromosomal gain and mutations of platelet-derived growth factor receptor-α gene in canine high-grade oligodendroglioma
    Kio Yoshida, James Kenn CHAMBERS, Kazuyuki Uchida · 2025 · Veterinary Pathology
  35. Incidental Diffuse Midline Glioma, H3 K27-Altered of the Pons Without Significant Coalterations
    Kee Kiat Yeo, Phoebe Power, Hart G.W. Lidov, Tom Rosenberg, Katherine E Warren, Edward R. Smith, Daphne Adele Haas-Kogan, Pratiti Bandopadhayay · 2025 · JCO Precision Oncology
  36. CD155 regulates tumor growth and immune evasion in diffuse midline glioma
    Theophilos Tzaridis, Ester Calvo Fernández, Tanja Eisemann, Augusto Faria Andrade, Carlos Alberto Oliveira de Biagi, Jennifer L. Hope, Oren Josh Becher, Nada Jabado, Jon D. Larson, Suzanne J. Baker et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Single‐Cell Profiling of Pediatric High‐Grade Gliomas Reveals OPC‐Like Subpopulations Driving Tumorigenic Lineage Transitions
    Tian Tian, Chong Huang, Lusheng Li · 2025 · Pediatric Discovery
  38. Organoids in pediatric cancer research
    Carla Ríos Arceo, Jarno Drost · 2025 · FEBS Letters
  39. Advances in preclinical models for pediatric diffuse intrinsic pontine glioma
    Bieke Van den Ende, Frederik De Smet, Sandra A. Jacobs, An Coosemans, Mattéo Riva · 2025 · International Journal of Cancer
  40. Additional file 1 of High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
    Wanming Hu, Duan, Hao, Sheng Zhong, Zeng, Jing, Mou, Yonggao · 2022 · Figshare
  41. Additional file 2 of High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
    Wanming Hu, Duan, Hao, Zhong, Sheng, Zeng, Jing, Mou, Yonggao · 2022 · Figshare
  42. Additional file 4 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Ishi, Yukitomo, Eugene Chekalin, Zeng, Billy, Glicksberg, Benjamin S., Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  43. Additional file 1 of Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas
    Xin Wei, Michaël Hananja Meel, Marjolein Breur, Marianna Bugiani, Esther Hulleman, Timothy N. Phoenix · 2021 · Figshare
  44. Additional file 1 of Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
    Nichole Lewis, Rachel Herndon Klein, Cailin Kelly, Yee, Jennifer, Paul S. Knoepfler · 2022 · Figshare
  45. Real-time monitoring of pediatric high-grade glioma invasion using organotypic brain cultures reveals a developmentally dependent sensitivity
    Yoav Biala, Ramakrishna Sai kumar Aravapalli, Hala A. Shalata, Zakhariya Manevitch, Oded Behar · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  46. A bibliometric analysis of progress and trends in pediatric glioma research
    M Wang, Chenchen Wu, Zhen Zhang, Xiwei Li, Junyi Liao, Mingyue Zhang, Enlin Jian, Xi Yu, Yanfeng Zhu, Peiling Cai · 2026 · Discover Oncology
  47. CBFA2T2: a novel H3K27 reader regulating metabolism and tumor growth
    Shengfei He, Yutian Ou, Fangfang Jiao, Jiuxing Feng, Ping Zhu, Jie Ma, Ning Xu, Haitao Li, Rui Guo · 2026 · Molecular Cancer
  48. Comparative analysis of clinical characteristics and prognostic factors in adult and pediatric patients with H3K27M-mutant diffuse midline glioma
    Rui Zhang, Gaoyue Jiang, Youheng Peng, Yan Ju, Yanhui Liu, Qing Mao, Yuan Yang, Yunhui Zeng, Peizhi Zhou, Q Li et al. · 2026 · Neurosurgical Review
  49. Développement et caractérisation de modèles vitro et vivo de cancers pédiatriques infiltrant du tronc cérébral (DIPG)
    Alexandre Plessier · 2018
  50. The tale of the histone H3.3 tail An essential role for the histone variant H3.3S31 residue during gastrulation in Xenopus
    David Sitbon · 2018 · theses.fr (ABES)
  51. Role of histone variant H3.3 mutations in the development of pediatric high-grade glioma
    Alexia Vidal · 2019 · theses.fr (ABES)
  52. Modulation of tumor invasion through the alteration of the cell identity in pediatric Diffuse Midline Gliomas
    Hoa Nguyen · 2024
  53. Nouvelles stratégies thérapeutiques dans le traitement du gliome infiltrant du tronc cérébral
    Guillaume Herrault · 2024
  54. A case report about extracranial skeletal metastases in pediatric diffuse midline glioma, H3 K27-altered
    Juan Wang, Yi Xing, Xueying Zhao, Yimin Cao, Ning Zheng, Wei Wang, Lixia Zhou · 2026 · Child s Nervous System
  55. Assessment system for short-term lower cranial nerve dysfunction following medulla oblongata glioma surgery: risk stratification and optimal surgical strategy
    Mingxin Zhang, Xiong Xiao, Heyuan Jia, Yinan Liu, Wenju Jiang, Luyang Xie, Changcun Pan, Zhen Wu, Junting Zhang, Liwei Zhang et al. · 2026 · Journal of neurosurgery
  56. Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data
    Dandan Wang, Xiaohao Liu, Juan Wang, Boya Zhang, Suna Zhai, Jiayao Xu, Long Wang, Yingjuan Zheng, Wei Wei, Yubing Zhou · 2026 · Journal of Neuro-Oncology
  57. Interpretation of Epidemiological Studies on the Relationship Between Mobile Phone Use and Cancer
    Michael Kundi, Hans-Peter Hutter · 2026 · Epidemiologia
  58. Modeling diffuse midline glioma through triple-electrode in utero electroporation of the developing mouse pons
    Molly A. Mason, Hosbaldo Morales Murillo, Madisyn G. Dudek, Samantha E Maher, Santos J. Franco · 2026 · PLoS ONE
  59. Clinical and molecular divergences in diffuse midline glioma, H3 K27-altered: A comparative study of survival outcomes in 1498 adults and children
    Wan Jing Tay, Yu Yang Soon, Song Chuan Aaron Foo, Balamurugan A. Vellayappan, Vincent Diong Weng Nga, Andrea Wong, Char Loo Tan · 2026 · Neuro-Oncology Practice
  60. Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma
    Zili Zhen, Qiang Gao, Yong Ai, Zhihong Qian, Yukui Shang, Yafang Deng, Shuai Chen, Xin Ni, Wei Zhang · 2026 · Molecular Therapy Oncology
  61. A pontine-specific niche supports de novo gliomagenesis
    Adrija Pathak, Gregg B. Wells, Vytas A. Bankaitis, Zhigang Xie · 2026 · Cell Reports
  62. CD155 regulates tumor growth and susceptibility to T cell-mediated killing in diffuse midline glioma
    Theophilos Tzaridis, Ester Calvo Fernández, Tanja Eisemann, Angela Liou, Augusto Faria Andrade, Carlos Alberto Oliveira de Biagi, Jennifer L. Hope, Liam Hewson, Michael McNicholas, Antonella De Cola et al. · 2026 · Neuro-Oncology
  63. Cell autonomous regional differences in oligodendrocyte lineage development and responses to oncohistone H3.3 K27M
    Jared M. Andrews, Kaitlin M. Budd, Chang-Hyuk Kwon, Jon D. Larson, Abbas Shirinifard, Lawryn H. Kasper, Chanrika C. Williams, Alfonso Lavado, Sharon King, Jorge Gutierrez et al. · 2026 · Nature Communications
  64. Spatial enrichment of PTPRZ1 in the peritumoral niche drives glioblastoma migration via the OPA1/ROS/CDH2 axis
    Li Yi, Shuhang Qin, Min Guo, Xuya Wang, Yiming Zhang, Peiquan Guo, Arne Östman, Xuejun Yang, Xiaobing Jiang · 2026 · Journal of Translational Medicine
  65. Chromatin adaptation and histone remodeling as mechanisms of PARP inhibitor resistance and therapeutic vulnerability
    Woori Bae, Eun A. Ra, Myon‐Hee Lee · 2026 · Frontiers in Pharmacology